A detailed history of Aspire Private Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Aspire Private Capital, LLC holds 90 shares of ZTS stock, worth $15,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 90 -0.0%
Holding current value
$15,926
Previous $15,000 13.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 30, 2023

SELL
$145.48 - $175.02 $436 - $525
-3 Reduced 3.23%
90 $14,000
Q1 2023

May 03, 2023

SELL
$145.48 - $175.02 $436 - $525
-3 Reduced 3.23%
90 $14,000
Q4 2022

May 30, 2023

BUY
$131.14 - $157.47 $393 - $472
3 Added 3.33%
93 $13,000
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $296 - $365
-2 Reduced 2.11%
93 $14,000
Q1 2022

May 10, 2022

SELL
$181.39 - $234.03 $7,255 - $9,361
-40 Reduced 29.63%
95 $18,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $7,360 - $9,387
38 Added 39.18%
135 $33,000
Q1 2021

May 26, 2021

BUY
$144.0 - $169.39 $7,200 - $8,469
50 Added 106.38%
97 $15,000
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $9,322 - $11,245
-68 Reduced 59.13%
47 $8,000
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $11,975 - $15,250
107 Added 1337.5%
115 $16,000
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $4,169 - $6,522
-45 Reduced 84.91%
8 $1,000
Q4 2019

Feb 11, 2020

BUY
$116.25 - $133.25 $5,231 - $5,996
45 Added 562.5%
53 $7,000
Q2 2019

Aug 13, 2019

SELL
$97.98 - $114.28 $391 - $457
-4 Reduced 33.33%
8 $1,000
Q1 2019

May 13, 2019

SELL
$81.56 - $100.67 $570 - $704
-7 Reduced 36.84%
12 $1,000
Q4 2018

Feb 25, 2019

BUY
$79.28 - $95.27 $1,347 - $1,619
17 Added 850.0%
19 $2,000
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $158 - $190
2 New
2 $2,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.